Intravenous magnesium sulphate for aneurysmal subarachnoid hemorrhage: an updated systemic review and meta-analysis

Table 1 Outcome parameters of the randomized controlled clinical trials included

Trial	Patient number	Serious adverse events	Delayed cerebral ischemia	Delayed cerebral infarction	Three-month favorable outcome	Three-month excellent outcome	Six-month favorable outcome	Six-month excellent outcome
Veyna 2002 [6]	40	No	No	No	Yes	No	No	No
van den Bergh 2005 [30]	283	Not mentioned	No	No	Yes	No	No	No
Wong 2006 [9]	60	No	No	No	No	No	Yes	Yes
Muroi 2008 [11]	58	Hypotension (12), cardiac events (4)	No	Yes	Yes	Yes	No	No
Westermaier 2010 [13]	107	Hypocalcemic tetany (1)	Yes	Yes	No	No	Yes	Yes
Wong 2010 [12]	327	Limb weakness (1), severe electrolyte disturbance (1)	Yes	Yes	No	No	Yes	Yes

The terminologies for delayed cerebral ischemia, delayed cerebral infarction, and favorable and excellent outcome are defined in the Materials and methods section.

ISSN: 1364-8535